Skip to main content
. 2021 Feb 20;10(4):874. doi: 10.3390/jcm10040874

Figure 1.

Figure 1

Survival curve was measured from v0 until the end of follow-up (v60) or progression/death in 116 patients at risk with RA-ILD under treatment with DMARDs.